1 Petersson J, Glenny RW. Gas exchange and ventilation-perfusion relationships in the lung. Eur Respir J. 2014;44(4):1023–41.
2 Kroegel C. Klinische Pneumologie. 2014; p 89.
3 Cheng TO. Platypnea-orthodeoxia syndrome: etiology, differential diagnosis, and management. Catheter Cardiovasc Interv. 1999;47(1):64–6.
4 Mojadidi MK, Ruiz JC, Chertoff J, Zaman MO, Elgendy IY, Mahmoud AN, et al. Patent Foramen Ovale and Hypoxemia. Cardiol Rev. 2019;27(1):34–40.
5 Layoun ME, Aboulhosn JA, Tobis JM. Potential Role of Patent Foramen Ovale in Exacerbating Hypoxemia in Chronic Pulmonary Disease. Tex Heart Inst J. 2017;44(3):189–97.
6 Tobis JM, Narasimha D, Abudayyeh I. Patent Foramen Ovale Closure for Hypoxemia. Interv Cardiol Clin. 2017;6(4):547–54.
7 Robin ED, Laman D, Horn BR, Theodore J. Platypnea related to orthodeoxia caused by true vascular lung shunts. N Engl J Med. 1976;294(17):941–3.
8 Kerut EK, Norfleet WT, Plotnick GD, Giles TD. Patent foramen ovale: a review of associated conditions and the impact of physiological size. J Am Coll Cardiol. 2001;38(3):613–23.
9 Mojadidi MK, Gevorgyan R, Noureddin N, Tobis JM. The effect of patent foramen ovale closure in patients with platypnea-orthodeoxia syndrome. Catheter Cardiovasc Interv. 2015;86(4):701–7.